Annals of the Rheumatic Diseases: 81 (6)

Editorials

Reflections on a contemporary European tragedy (25 April, 2022) Free
Iain B McInnes, Annamaria Iagnocco, Daniel Aletaha, Xenofon Baraliakos, Johannes WJ Bijlsma, Elsa F Mateus, Zoltan Szekanecz, Theodora P M Vliet Vlieland, Josef S Smolen
Greetings from the editor (16 May, 2022) Free
Josef S Smolen

Heroes and pillars of rheumatology

EULAR 75-year anniversary: commentaries on key ARD papers from 1947 (16 May, 2022) Free
Tore K Kvien

Views on news

Treatment of lupus: more options after a long wait (13 January, 2022)
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
In the shadow of antibodies: how T cells defend against COVID-19 (7 April, 2022)
David S Pisetsky, Kevin L Winthrop

Recommendations

EULAR points to consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs) (10 December, 2021) Free
Christian Dejaco, Pedro M Machado, Francesco Carubbi, Philipp Bosch, Lene Terslev, Giorgio Tamborrini, Luca Maria Sconfienza, Carlo Alberto Scirè, Sebastian Ruetten, Jef van Rompay, Fabian Proft, Costantino Pitzalis, Marina Obradov, Rikke Helene Moe, Vasco V Mascarenhas, Clara Malattia, Andrea Sabine Klauser, Alison Kent, Lennart Jans, Wolfgang Hartung, Hilde Berner Hammer, Christina Duftner, Peter V Balint, Alessia Alunno, Xenofon Baraliakos
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome (2 February, 2022) Free
George C Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T Boumpas, Nina Brodin, Ian N Bruce, Miguel Ángel González-Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan Mukhtyar, Manuel Ramos-Casals, Naveed Sattar, Karen Schreiber, Savino Sciascia, Elisabet Svenungsson, Zoltan Szekanecz, Anne-Kathrin Tausche, Alan Tyndall, Vokko van Halm, Alexandre Voskuyl, Gary J Macfarlane, Michael M Ward, Michael T Nurmohamed, Maria G Tektonidou
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology (20 January, 2022) Free
Delphine Sophie Courvoisier, Kim Lauper, Joanna Kedra, Maarten de Wit, Bruno Fautrel, Thomas Frisell, Kimme L Hyrich, Florenzo Iannone, Pedro M Machado, Lykke Midtbøll Ørnbjerg, Ziga Rotar, Maria Jose Santos, Tanja A Stamm, Simon R Stones, Anja Strangfeld, Sytske Anne Bergstra, Robert B M Landewé, Axel Finckh
EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients’ questions (4 February, 2022) Free
Johannes WJ Bijlsma

Rheumatoid arthritis

Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries (22 March, 2022)
Benedicte Delcoigne, Lotta Ljung, Sella A Provan, Bente Glintborg, Merete Lund Hetland, Kathrine Lederballe Grøn, Ritva Peltomaa, Heikki Relas, Carl Turesson, Bjorn Gudbjornsson, Brigitte Michelsen, Johan Askling
Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study (13 January, 2022)
Farzin Khosrow-Khavar, Seoyoung C Kim, Hemin Lee, Su Been Lee, Rishi J Desai

Inflammatory arthritis

Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint (15 February, 2022)
Ricardo Grieshaber-Bouyer, Tarik Exner, Nicolaj S Hackert, Felix A Radtke, Scott A Jelinsky, Olha Halyabar, Alexandra Wactor, Elham Karimizadeh, Joseph Brennan, Jorge Schettini, Helena Jonsson, Deepak A Rao, Lauren A Henderson, Carsten Müller-Tidow, Hanns-Martin Lorenz, Guido Wabnitz, James A Lederer, Angela Hadjipanayis, Peter A Nigrovic

Psoriatic arthritis

Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis (3 March, 2022)
Philip J Mease, Atul A Deodhar, Désirée van der Heijde, Frank Behrens, Alan J Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak, Subhashis Banerjee
Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study (24 February, 2022)
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatríz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Elke Theander, Josef S Smolen

Spondyloarthritis

Factors predicting axial spondyloarthritis among first-degree relatives of probands with ankylosing spondylitis: a family study spanning 35 years (11 March, 2022) Free
Sjef M van der Linden, Muhammad Asim Khan, Zhixiu Li, Heinz Baumberger, Hermine van Zandwijk, Kazim Khan, Peter M Villiger, Matthew A Brown

Polymyalgia rheumatic

Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial (24 February, 2022)
Michael Bonelli, Helga Radner, Andreas Kerschbaumer, Daniel Mrak, Martina Durechova, Jutta Stieger, Rusmir Husic, Peter Mandl, Josef S Smolen, Christian Dejaco, Daniel Aletaha

Systemic lupus erythematosus

Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus (2 March, 2022)
Yusuke Takeshima, Yukiko Iwasaki, Masahiro Nakano, Yuta Narushima, Mineto Ota, Yasuo Nagafuchi, Shuji Sumitomo, Tomohisa Okamura, Keith Elkon, Kazuyoshi Ishigaki, Akari Suzuki, Yuta Kochi, Kazuhiko Yamamoto, Keishi Fujio

Systemic sclerosis

Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease (21 February, 2022)
Shervin Assassi, Elizabeth R Volkmann, W Jim Zheng, Xuan Wang, Holly Wilhalme, Marka A Lyons, Michael D Roth, Donald P Tashkin

Vasculitis

Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study (21 February, 2022)
Matthew J Koster, Cynthia S Crowson, Rachel E Giblon, Jane M Jaquith, Ali Duarte-García, Eric L Matteson, Cornelia M Weyand, Kenneth J Warrington

Epidemiology

Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort (8 February, 2022)
Sakir Ahmed, Pankti Mehta, Aby Paul, S Anu, Somy Cherian, Veena Shenoy, Kaveri K Nalianda, Sanjana Joseph, Anagha Poulose, Padmanabha Shenoy
Efficacy of COVID-19 vaccines in patients taking immunosuppressants (23 February, 2022)
Chen Shen, Malcolm Risk, Elena Schiopu, Salim S Hayek, Tiankai Xie, Lynn Holevinski, Cem Akin, Gary Freed, Lili Zhao
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases (14 March, 2022)
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik N Albach, Jens Klotsche, Veronika Scholz, Lara Maria Jeworowski, Tatjana Schwarz, Alexander ten Hagen, Jan Zernicke, Victor Max Corman, Christian Drosten, Gerd-Rüdiger Burmester, Robert Biesen
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial (22 February, 2022)
Carlo Scognamiglio Renner Araujo, Ana Cristina Medeiros-Ribeiro, Carla G S Saad, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Matheus Santos Rodrigues Silva, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Tatiana Pedrosa, Leonard de Vinci Kanda Kupa, Gioanna Zou, Rosa M R Pereira, Clóvis Artur Silva, Nádia Emi Aikawa, Eloisa Bonfa

Letters

Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021 (27 January, 2022)
Abhishek Abhishek, Laila J Tata, Mamas Mamas, Anthony J Avery
Effectiveness and safety of combined biological therapy in patients with refractory multidomain spondyloarthritis (27 January, 2022)
Cristina Valero, Juan Pablo Baldivieso, Isidoro Gonzalez-Alvaro, Eva Tomero, Santos Castañeda, Rosario García-Vicuña
Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity (28 January, 2022)
François Chasset, Alexis Mathian, Karim Dorgham, Camillo Ribi, Marten Trendelenburg, Uyen Huynh-Do, Pascale Roux-Lombard, Delphine Sophie Courvoisier, Zahir Amoura, Guy Gorochov, Carlo Chizzolini
ADAMTS5 as a therapeutic target for osteoarthritis: Mendelian randomisation study (7 February, 2022)
Sizheng Steven Zhao, Ville Karhunen, Andrew P Morris, Dipender Gill

EULAR news

An extraordinary 75 years of EULAR (16 May, 2022) Free
EULAR Communications

Electronic pages

Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis (5 February, 2020) Free
Dennis Scheicht
Response to: ‘Error in the dosage of methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis’ by Scheicht (15 February, 2022) Free
Chetan B Mukhtyar, Bernhard Hellmich
Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome (11 June, 2020) Free
Wenhui Xie, Hong Huang, Zhuoli Zhang
Response to: ‘Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome’ by Xie et al
(11 June, 2020) Free
Yueting Li, Yihan Cao, Chen Li, Wen Zhang
Comment on ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al
(24 June, 2020) Free
Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Murat Torgutalp, Hildrun Haibel, Janis Lucas Vahldiek, Ann-Christin von Brünneck, Safwan Omran, Denis Poddubnyy, Fabian Proft
Response to: ‘Comment on ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al’ by Rios Rodriguez et al
(24 June, 2020) Free
Shun Tanimura, Hiroyuki Nakamura, Tetsuya Horita
Bowman’s capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications (12 June, 2020) Free
Vincenzo L'Imperio, Gisella Vischini, Fabio Pagni, Pietro Manuel Ferraro
Response to: ‘Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications’ by L'Imperio et al
(12 June, 2020) Free
Dilek Solmaz, Servet Akar
Pisotriquetral arthritis: ‘forgotten’ joint in ultrasound imaging of the wrist (8 June, 2020) Free
Andrea Becciolini, Alarico Ariani, Marco Becciolini
Response to: ‘Pisotriquetral arthritis: ‘forgotten’ joint in ultrasound imaging of the wrist’ by Becciolini et al
(8 June, 2020) Free
Andrea Di Matteo, Kulveer Mankia, Richard J Wakefield, Paul Emery
Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease-associated macrophage activation syndrome (1 July, 2020) Free
Lei Zhang, Xiaopei Yang, Tian-Fang Li, Xiaojun Liu, Shengyun Liu
Response to: ‘Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease associated macrophage activation syndrome’ by Zhang et al
(1 July, 2020) Free
Francesca Minoia, Angelo Ravelli
Understanding bone fragility: theoretical explanation to non-physician health professionals (19 June, 2020) Free
Toshihiro Sugiyama
Response to: ‘Understanding bone fragility: theoretical explanation to non-physician health professionals’ by Sugiyama (19 June, 2020) Free
Jo Adams, Nicky Wilson, Tanja A Stamm
Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still’s disease (3 July, 2020) Free
Piero Ruscitti, Tanja A Stamm, Roberto Giacomelli
Response to: ‘Changing the outcome measures, changing the results? The urgent need of a specific Disease Activity Score to adult-onset Still’s disease’ by Ruscitti et al
(3 July, 2020) Free
Claudia Kedor, Joachim Listing, Jan Zernicke, Eugen Feist
Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues (22 June, 2020) Free
Hadis Ghajari, Siamak Sabour
Response to: ‘Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues’ by Ghajari and Sabour (22 June, 2020) Free
Kornelis SM van der Geest, Frances Borg, Abdul Kayani, Davy Paap, Prisca Gondo, Wolfgang Schmidt, Raashid Ahmed Luqmani, Bhaskar Dasgupta
Correspondence to ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’ (19 June, 2020) Free
Kevin Sheng-Kai Ma, James Cheng-Chung Wei, Wen-Hung Chung
Response to: ‘Correspondence to “Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’ by Ma et al
(19 June, 2020) Free
Jasvinder A Singh
Correction: EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
(16 May, 2022) Free

Main menu

Table of contents

June 2022 - Volume 81 - 6

Editorials

Heroes and pillars of rheumatology

Views on news

Recommendations

Rheumatoid arthritis

Inflammatory arthritis

Psoriatic arthritis

Spondyloarthritis

Polymyalgia rheumatic

Systemic lupus erythematosus

Systemic sclerosis

Vasculitis

Epidemiology

Letters

EULAR news

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

June 2022 - Volume 81 - 6

Editorials

Heroes and pillars of rheumatology

Views on news

Recommendations

Rheumatoid arthritis

Inflammatory arthritis

Psoriatic arthritis

Spondyloarthritis

Polymyalgia rheumatic

Systemic lupus erythematosus

Systemic sclerosis

Vasculitis

Epidemiology

Letters

EULAR news

Electronic pages

Issue Information